EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

SARS‐CoV‐2 Spike Protein Induces Time‐Dependent CTSL Upregulation in HeLa Cells and Alveolarspheres

Magdalena M Bolsinger iD, Alice Drobny, Sibylle Wilfling, Stephanie Reischl, Florian Krach, Raul Moritz, Denise Balta, Ute Hehr, Elisabeth Sock, Florian Bleibaum, Frank Hanses, Beate Winner und 3 weitere

Journal of Cellular Biochemistry · 2024

DOI: 10.1002/jcb.30627 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Biochemistry, 2024. Verfasst von Magdalena M Bolsinger und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, Cathepsin L, SARS-CoV-2, COVID-19. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Bayerisches Staatsministerium für Wissenschaft und Kunst, IZKF, Medical Faculty FAU University Erlangen-Nuremberg, Deutsche Forschungsgemeinschaft (DFG).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autophagy and lysosomal pathways are involved in the cell entry of SARS‐CoV‐2 virus. To infect the host cell, the spike protein of SARS‐CoV‐2 binds to the cell surface receptor angiotensin‐converting enzyme 2 (ACE2). To allow the fusion of the viral envelope with the host cell membrane, the spike protein has to be cleaved. One possible mechanism is the endocytosis of the SARS‐CoV‐2–ACE2 complex and subsequent cleavage of the spike protein, mainly by the lysosomal protease cathepsin L. However, detailed molecular and dynamic insights into the role of cathepsin L in viral cell entry remain elusive. To address this, HeLa cells and iPSC‐derived alveolarspheres were treated with recombinant SARS‐CoV‐2 spike protein, and the changes in mRNA and protein levels of cathepsins L, B, and D were monitored. Additionally, we studied the effect of cathepsin L deficiency on spike protein internalization and investigated the influence of the spike protein on cathepsin L promoters in vitro. Furthermore, we analyzed variants in the genes coding for cathepsin L, B, D, and ACE2 possibly associated with disease progression using data from Regeneron's COVID Results Browser and our own cohort of 173 patients with COVID‐19, exhibiting a variant of ACE2 showing significant association with COVID‐19 disease progression. Our in vitro studies revealed a significant increase in cathepsin L mRNA and protein levels following exposure to the SARS‐CoV‐2 spike protein in HeLa cells, accompanied by elevated mRNA levels of cathepsin B and D in alveolarspheres. Moreover, an increase in cathepsin L promoter activity was detected in vitro upon spike protein treatment. Notably, the knockout of cathepsin L resulted in reduced internalization of the spike protein. The study highlights the importance of cathepsin L and lysosomal proteases in the SARS‐CoV‐2 spike protein internalization and suggests the potential of lysosomal proteases as possible therapeutic targets against COVID‐19 and other viral infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spike Glycoprotein, CoronavirusCathepsin LSARS-CoV-2COVID-19Angiotensin-Converting Enzyme 2HumansHeLa CellsUp-RegulationVirus Internalization

Stichwörter der Autor:innen

SARS‐CoV‐2cathepsin Lcathepsinslysosomesspike protein

Substanzen

Spike Glycoprotein, CoronavirusCathepsin Lspike protein, SARS-CoV-2CTSL protein, humanAngiotensin-Converting Enzyme 2ACE2 protein, human

Autor:innen und Institutionen

  • Department of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Center for Human Genetics Regensburg, Regensburg, Germany.
  • Department of Stem Cell Biology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Institut für Biochemie, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Institute of Biochemistry, Christian-Albrechts-University Kiel, Kiel, Germany.
  • Emergency Department, University Hospital Regensburg, Regensburg, Germany.

ORCID-Profile: Magdalena M Bolsinger, Philipp Arnold, Friederike Zunke

Förderung

  • Bayerisches Staatsministerium für Wissenschaft und Kunst
  • IZKF, Medical Faculty FAU University Erlangen-Nuremberg
  • Deutsche Forschungsgemeinschaft (DFG)

Zitieren

APA

Bolsinger, M. M., Drobny, A., Wilfling, S., Reischl, S., Krach, F., Moritz, R., Balta, D., Hehr, U., Sock, E., Bleibaum, F., Hanses, F., Winner, B., Huarcaya, S. P., Arnold, P., & Zunke, F. (2024). SARS‐CoV‐2 Spike Protein Induces Time‐Dependent CTSL Upregulation in HeLa Cells and Alveolarspheres. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.30627

Vancouver

Bolsinger MM, Drobny A, Wilfling S, Reischl S, Krach F, Moritz R, et al. SARS‐CoV‐2 Spike Protein Induces Time‐Dependent CTSL Upregulation in HeLa Cells and Alveolarspheres. Journal of Cellular Biochemistry. 2024. doi:10.1002/jcb.30627

BibTeX
@article{Bolsinger2024,
  author = {Bolsinger, Magdalena M and Drobny, Alice and Wilfling, Sibylle and Reischl, Stephanie and Krach, Florian and Moritz, Raul and Balta, Denise and Hehr, Ute and Sock, Elisabeth and Bleibaum, Florian and Hanses, Frank and Winner, Beate and Huarcaya, Susy Prieto and Arnold, Philipp and Zunke, Friederike},
  title = {SARS‐CoV‐2 Spike Protein Induces Time‐Dependent CTSL Upregulation in HeLa Cells and Alveolarspheres},
  journal = {Journal of Cellular Biochemistry},
  year = {2024},
  doi = {10.1002/jcb.30627}
}
Kostenlos starten →